Genomics
Latest round
- Series B
Last raised
- Dec 2018
Total raised
- $61M
Investors
- 12
About Genomics
Based in Oxford, the UK and founded in 2014 by CEO Professor Peter Donnelly, Professor Gil McVean, Dr. Gerton Lunter, and Dr. Chris Spencer, Genomics plc is a healthcare company that uses large-genetic information to develop precision healthcare tools and engage in drug discovery for individuals as well as for health systems., collaborated with Genomic plc for three years, extendable to five years, to use human genetics to improve the discovery of drugs for precision medicines. In 2020, Genomics plc incorporated its US subsidiary, Genomic Inc. In 2021, Genomics plc launched a pilot study to predict patients’ risk of heart disease using an integrated polygenic and clinical risk tool. As of 2021, the company staffs over 100 employees across three offices in the UK and the US. The company’s algorithms and databases link minute variations across human genomes to changes in thousands of biological measurements and disease outcomes. Genomics also delivers insights for healthcare systems, clinicians, and pharmaceutical companies. The company’s products are offered through its precision health division and therapeutics division. Genomics plc measures an individual’s genetic code and provides preventive solutions for genetic risks and other non-genetic factors including risk for cancers, cardiovascular diseases, autoimmune disorders, and diabetes. The company provides a polygenic risk score as a summary of genetic predisposition to a particular health condition for over 30 diseases. Genomics’s therapeutics division is engaged in the discovery and development of new medicines.
Who invested in Genomics
12 investors across 4 rounds
See all investors in Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Genomics
Who invested in Genomics?
Genomics has 12 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Genomics raised?
Genomics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Genomics last raise money?
Genomics's most recent round on record is a Series B, in Dec 2018.
What does Genomics do?
Based in Oxford, the UK and founded in 2014 by CEO Professor Peter Donnelly, Professor Gil McVean, Dr.
Where is Genomics headquartered?
Genomics is headquartered in Oxford, UK.
Which VCs invest in companies like Genomics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Genomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.